Latest News about Biotech
Recent news which mentions Biotech
Y-mAbs' Omburtamab Failure: The Critical Turning Point And $19.65M Shareholder Settlement
November 22, 2024
Tickers
YMAB
From Benzinga
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
From Benzinga
Traceable, Reliable, Stable Seeds: Dutch Passion, The Cannabis Biotech You Didn't Know You Needed
November 21, 2024
Tickers
NEWS
From Benzinga
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
November 21, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
November 21, 2024
From Benzinga
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
November 21, 2024
From Benzinga
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards
November 20, 2024
From Benzinga
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
November 20, 2024
From Benzinga
Cannabis Robots And The Search For Good Jobs: A Veteran's Mission To Keep The US Ahead In The Tech Race
November 20, 2024
From Benzinga
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.